Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome R Marfella, M Siniscalchi, K Esposito, A Sellitto, U De Fanis, C Romano, ... Diabetes care 26 (11), 3129-3135, 2003 | 329 | 2003 |
Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels M Persico, E Persico, R Suozzo, S Conte, M de Seta, L Coppola, ... Gastroenterology 118 (4), 760-764, 2000 | 315 | 2000 |
Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with … FC Sasso, D Torella, O Carbonara, GM Ellison, M Torella, M Scardone, ... Journal of the American College of Cardiology 46 (5), 827-834, 2005 | 225 | 2005 |
Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients M Secondulfo, D Iafusco, R Carratu, L deMagistris, A Sapone, ... Digestive and Liver Disease 36 (1), 35-45, 2004 | 221 | 2004 |
Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome K Esposito, M Ciotola, D Carleo, B Schisano, F Saccomanno, FC Sasso, ... Diabetes care 29 (5), 1071-1076, 2006 | 180 | 2006 |
The importance of telemedicine during COVID-19 pandemic: a focus on diabetic retinopathy R Galiero, PC Pafundi, R Nevola, L Rinaldi, C Acierno, A Caturano, ... Journal of diabetes research 2020, 2020 | 171 | 2020 |
The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment R Marfella, M D’Amico, K Esposito, A Baldi, C Di Filippo, M Siniscalchi, ... Diabetes 55 (3), 622-632, 2006 | 161 | 2006 |
Glucose metabolism and coronary heart disease in patients with normal glucose tolerance FC Sasso, O Carbonara, R Nasti, B Campana, R Marfella, M Torella, ... Jama 291 (15), 1857-1863, 2004 | 161 | 2004 |
Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes R Marfella, K Esposito, F Nappo, M Siniscalchi, FC Sasso, M Portoghese, ... Diabetes 53 (9), 2383-2391, 2004 | 149 | 2004 |
Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines F Morgillo, FC Sasso, CM Della Corte, D Vitagliano, E D'Aiuto, T Troiani, ... Clinical Cancer Research 19 (13), 3508-3519, 2013 | 137 | 2013 |
Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review L Rinaldi, PC Pafundi, R Galiero, A Caturano, MV Morone, C Silvestri, ... Antioxidants 10 (2), 270, 2021 | 132 | 2021 |
Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with Type 2 diabetes mellitus R Marfella, F Cacciapuoti, M Siniscalchi, FC Sasso, F Marchese, F Cinone, ... Diabetic Medicine 23 (9), 974-981, 2006 | 132 | 2006 |
LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the “LOWERING-IT” Trial M Torella, D Torella, P Chiodini, M Franciulli, G Romano, L De Santo, ... American heart journal 160 (1), 171-178, 2010 | 123 | 2010 |
Effects of metformin therapy on coronary endothelial dysfunction in patients with prediabetes with stable angina and nonobstructive coronary artery stenosis: the CODYCE … C Sardu, P Paolisso, C Sacra, C Mauro, F Minicucci, M Portoghese, ... Diabetes Care 42 (10), 1946-1955, 2019 | 122 | 2019 |
Regression of carotid atherosclerosis by control of morning blood pressure peak in newly diagnosed hypertensive patients R Marfella, M Siniscalchi, F Nappo, P Gualdiero, K Esposito, FC Sasso, ... American journal of hypertension 18 (3), 308-318, 2005 | 119 | 2005 |
Efficacy and durability of multifactorial intervention on mortality and MACEs: A randomized clinical trial in type-2 diabetic kidney disease FC Sasso, PC Pafundi, V Simeon, L De Nicola, P Chiodini, R Galiero, ... Cardiovascular Diabetology 20, 1-12, 2021 | 109 | 2021 |
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage M Masarone, V Rosato, A Aglitti, T Bucci, R Caruso, T Salvatore, ... PLoS one 12 (6), e0178473, 2017 | 106 | 2017 |
Carbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathy D Torella, GM Ellison, M Torella, C Vicinanza, I Aquila, C Iaconetti, ... Journal of the American Heart Association 3 (2), e000434, 2014 | 106 | 2014 |
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy FC Sasso, L De Nicola, O Carbonara, R Nasti, R Minutolo, T Salvatore, ... Diabetes Care 29 (3), 498-503, 2006 | 106 | 2006 |
Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients R Marfella, FC Sasso, M Siniscalchi, M Cirillo, P Paolisso, C Sardu, ... Journal of the American College of Cardiology 62 (6), 525-530, 2013 | 104 | 2013 |